Most Australians want the maximum price of PBS medicines capped at $25 or less, according to new polling released by the ...
A group of students from across Australia spent two days in Canberra finding out how many doors a career in health can open.
The NDIS can fund an assistance dog's food, vet bills and grooming year after year. Meanwhile, women with breast cancer that has spread to the brain are denied funded access, and children with Crohn's ...
A small Melbourne company founded by two medical researchers has landed one of Australia's biggest potential licensing deals.
The real story is that per capita spending on the program, accounting for inflation and population growth, remains where it ...
Melbourne biotech Magellan Stem Cells is 17 years old and about to begin a pivotal Phase 3 trial of its stem cell treatment ...
Net spending on the Pharmaceutical Benefits Scheme rose by about $1.5 billion in 2025-26 as rebates paid by medicine ...
Dr Brian McNamee AO will retire from CSL's board in March next year, and Gordon Naylor, who has served as Interim CEO and Managing Director since February, will become the company's chair.
The current agreement between the Commonwealth and the research-based pharmaceutical industry promised faster access to new medicines through HTA reforms. Four years on, that reform is still ...
The melanoma study's principal investigator, Professor Georgina Long of Melanoma Institute Australia, said the results ...
Medicines Australia has added two new directors to its board. Anne Harris of Novartis and Ed Hollywood of Boehringer Ingelheim were elected in an October vote. They replace outgoing directors Melissa ...
New Zealand's National Party has put medicines back at the centre of its health campaign, promising an additional NZ$604 million for Pharmac if it returns to government at the 7 November election. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results